Home › Compare › IMMVF vs QYLD

IMMVF vs QYLD: Dividend Comparison 2026

IMMVF yields 10000.00% · QYLD yields 11.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IMMVF wins by $55137509079256512.00M in total portfolio value
10 years
IMMVF
IMMVF
● Live price
10000.00%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$55137509079256512.00M
Annual income
$54,073,795,673,722,890,000,000.00
Full IMMVF calculator →
QYLD
Global X Nasdaq 100 Covered Call ETF
● Live price
11.92%
Share price
$17.15
Annual div
$2.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.4K
Annual income
$5,659.31
Full QYLD calculator →

Portfolio growth — IMMVF vs QYLD

📍 IMMVF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIMMVFQYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IMMVF + QYLD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
IMMVF pays
QYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IMMVF
Annual income on $10K today (after 15% tax)
$850,000.00/yr
After 10yr DRIP, annual income (after tax)
$45,962,726,322,664,450,000,000.00/yr
QYLD
Annual income on $10K today (after 15% tax)
$1,013.51/yr
After 10yr DRIP, annual income (after tax)
$4,810.41/yr
At 15% tax rate, IMMVF beats the other by $45,962,726,322,664,450,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IMMVF + QYLD for your $10,000?

IMMVF: 50%QYLD: 50%
100% QYLD50/50100% IMMVF
Portfolio after 10yr
$27568754539628256.00M
Annual income
$27,036,897,836,861,443,000,000.00/yr
Blended yield
98.07%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IMMVF buys
0
QYLD buys
0
No recent congressional trades found for IMMVF or QYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIMMVFQYLD
Forward yield10000.00% ✓11.92%
Annual dividend / share$2.00$2.04 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$55137509079256512.00M ✓$25.4K
Annual income after 10y$54,073,795,673,722,890,000,000.00 ✓$5,659.31
Total dividends collected$55066727460582336.00M ✓$27.1K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: IMMVF vs QYLD ($10,000, DRIP)

YearIMMVF PortfolioIMMVF Income/yrQYLD PortfolioQYLD Income/yrGap
1← crossover$1,010,700$1,000,000.00$10,352$1,192.36+$1.00M → IMMVF
2$95,539,393$94,457,943.93$10,830$1,347.57+$95.53M → IMMVF
3$8,447,007,736$8,344,780,585.66$11,460$1,539.07+$8447.00M → IMMVF
4$698,565,746,383$689,527,448,105.17$12,275$1,777.84+$698565.73M → IMMVF
5$54,040,711,670,213$53,293,246,321,583.74$13,323$2,078.95+$54040711.66M → IMMVF
6$3,910,851,616,519,516$3,853,028,055,032,387.00$14,667$2,463.34+$3910851616.50M → IMMVF
7$264,781,167,546,477,440$260,596,556,316,801,570.00$16,396$2,960.57+$264781167546.46M → IMMVF
8$16,772,556,223,821,672,000$16,489,240,374,546,942,000.00$18,631$3,612.97+$16772556223821.65M → IMMVF
9$994,124,678,068,810,000,000$976,178,042,909,320,800,000.00$21,548$4,482.15+$994124678068810.00M → IMMVF
10$55,137,509,079,256,515,000,000$54,073,795,673,722,890,000,000.00$25,398$5,659.31+$55137509079256512.00M → IMMVF

IMMVF vs QYLD: Complete Analysis 2026

IMMVF — Stock

Immunovia AB (publ), a diagnostic company, develops and commercializes blood tests in Sweden and internationally. The company's product includes IMMray PanCan-d, a blood-based test for the early detection of pancreatic cancer. It also develops research projects for lung cancer. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.

Full IMMVF Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →
📬

Get this IMMVF vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IMMVF vs SCHDIMMVF vs JEPIIMMVF vs OIMMVF vs KOIMMVF vs MAINIMMVF vs XYLDIMMVF vs JEPQIMMVF vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.